KR20040072646A - 암치료용 약초 화학 조성물 - Google Patents

암치료용 약초 화학 조성물 Download PDF

Info

Publication number
KR20040072646A
KR20040072646A KR10-2004-7008727A KR20047008727A KR20040072646A KR 20040072646 A KR20040072646 A KR 20040072646A KR 20047008727 A KR20047008727 A KR 20047008727A KR 20040072646 A KR20040072646 A KR 20040072646A
Authority
KR
South Korea
Prior art keywords
composition
cancer
cells
growth
synergistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7008727A
Other languages
English (en)
Korean (ko)
Inventor
자나스와미 마드허수다나 라오
풀렐라 벤카타 스리니바스
질루 싱흐 야다브
콘다푸람 비자야 라그하반
에이. 케이. 삭세나
엠. 산무가벨
히마니 캄파시
굴람 나비 콰지
Original Assignee
카운실 오브 사이언티픽 엔드 인더스트리얼 리서치
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카운실 오브 사이언티픽 엔드 인더스트리얼 리서치 filed Critical 카운실 오브 사이언티픽 엔드 인더스트리얼 리서치
Publication of KR20040072646A publication Critical patent/KR20040072646A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR10-2004-7008727A 2001-12-05 2001-12-05 암치료용 약초 화학 조성물 Ceased KR20040072646A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000214 WO2003047608A1 (en) 2001-12-05 2001-12-05 A novel herbal chemical composition for the treatment of cancer

Publications (1)

Publication Number Publication Date
KR20040072646A true KR20040072646A (ko) 2004-08-18

Family

ID=11076415

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7008727A Ceased KR20040072646A (ko) 2001-12-05 2001-12-05 암치료용 약초 화학 조성물

Country Status (7)

Country Link
EP (1) EP1465645A1 (https=)
JP (1) JP2005511659A (https=)
KR (1) KR20040072646A (https=)
CN (1) CN100444837C (https=)
AU (1) AU2002222501A1 (https=)
CA (1) CA2469093A1 (https=)
WO (1) WO2003047608A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101416505B1 (ko) * 2012-03-15 2014-07-09 연세대학교 산학협력단 마타이레시놀을 포함하는 혈관신생 억제용 약제학적 조성물

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20106293A0 (fi) 2010-12-06 2010-12-06 Emilia Peuhu Uudet farmaseuttiset koostumukset
CN104523721A (zh) * 2014-11-11 2015-04-22 济南星懿医药技术有限公司 一种抗肿瘤的药物组合物
CN109206394B (zh) * 2018-08-16 2022-04-01 广西壮族自治区中国科学院广西植物研究所 一种倍半木脂素化合物、其制备方法及应用
CN113633704B (zh) * 2021-08-23 2022-06-07 中山大学 一种细轴荛花叶提取物的制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101416505B1 (ko) * 2012-03-15 2014-07-09 연세대학교 산학협력단 마타이레시놀을 포함하는 혈관신생 억제용 약제학적 조성물

Also Published As

Publication number Publication date
CN1582160A (zh) 2005-02-16
WO2003047608A1 (en) 2003-06-12
JP2005511659A (ja) 2005-04-28
CA2469093A1 (en) 2003-06-12
EP1465645A1 (en) 2004-10-13
CN100444837C (zh) 2008-12-24
AU2002222501A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
CN101485655B (zh) 二氢杨梅素在制备防治肿瘤放化疗不良反应的药物的应用
Queiroz et al. Comparative studies of the effects of Tabebuia avellanedae bark extract and β-lapachone on the hematopoietic response of tumour-bearing mice
US20040127561A1 (en) Pharmaceutical composition containing brevifoliol for use in chemotherapeutic treatment of human beings, method therefor
US6649650B2 (en) Herbal chemical composition for the treatment of cancer
KR20040072646A (ko) 암치료용 약초 화학 조성물
JPS61109713A (ja) 抗腫瘍剤
JPH02311462A (ja) 制ガン剤ならびに制ガン剤として有用な新規複素環化合物またはそれらの塩
JP2761876B2 (ja) 新規化合物、その製造方法及びその用途
AU605494B2 (en) The use of 15-deoxyspergualine as a pharmaceutical
US5663197A (en) 2-(1-hydroxyethyl)-5-hydroxynaphtho[2,3-b]furan-4,9-dione and antitumor agents comprising this compound
KR100830851B1 (ko) 미백활성 및 항염활성을 나타내는 비룡추출물
JP2988937B2 (ja) 海洋源由来の新規の抗腫瘍性及び抗ウイルス性組成物
KR100470150B1 (ko) 간섬유화 억제 활성을 갖는 메소-디히드로구아이레트산유도체
US6458831B1 (en) Use of two plant phenols in the treatment of arteriosclerosis
TWI646966B (zh) 製備昭和草萃取物之方法，藉此製備的萃取物及該萃取物之用途
KR0143718B1 (ko) 항암 활성을 갖는 신규 제리쿠드라닌 이 및 제이 화합물, 및 그의 제조방법
KR101813112B1 (ko) 신규한 세스퀴터펜 유도체, 이의 제조방법 및 이를 유효성분으로 하는 골 질환의 예방 또는 치료용 약학조성물
EP1313490A1 (en) Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
KR100466522B1 (ko) 항암활성을 갖는 ｊ 300 동충하초 추출물 및 이를함유하는 약제학적 조성물
KR100459088B1 (ko) 간세포 보호활성을 나타내는 비자나무의 수피로부터분리한 다이벤질부틸락톤 리그난 유도체 및 이를유효성분으로 함유하는 간세포 보호 및 간 질환 치료용조성물
KR20220036254A (ko) 돌단풍(Aceriphyllum rossii) 유래 3-하이드록시올레안-12-엔-27-오익산 또는 그의 유도체를 포함하는 골 용해성 질환의 예방 또는 치료용 조성물
CN116265455A (zh) 一类倍半萜-生物碱杂聚体及其制备方法和制药的用途
EP0486944A2 (en) Method of inhibiting tumor growth using xanthocillin X dimethylether
KR101609231B1 (ko) 솔잎 추출물로부터 분리된 신규 화합물을 함유하는 인체 파필로마바이러스(hpv) 억제 및 암질환 예방과 치료용 조성물
NZ510803A (en) Use of acylcarnitines as antitumour agents

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040605

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20060123

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20061107

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070919

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20080603

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20070919

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20080903

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20080603

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Appeal identifier: 2008101008943

Request date: 20080903

J501 Disposition of invalidation of trial
PJ0501 Disposition of invalidation of trial

Comment text: Request for Amendment

Patent event date: 20040611

Patent event code: PJ05011S01I

Appeal kind category: Appeal against decision to decline refusal

Request date: 20080903

Appeal identifier: 2008101008943